Oculis (NASDAQ:OCS – Free Report) had its price objective lowered by Robert W. Baird from $64.00 to $35.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities research analysts also recently weighed in on the stock. HC Wainwright reissued a […]